Figure 3
From: Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer
Representative images of immunofluorescence staining for CD63 and PSMA in patients with (A) benign prostatic hyperplasia and (B) prostate cancer. (C) Quantification of PSMA-positive areas in prostatic tissue (p < 0.001).
